Effectiveness of Laser Photobiomodulation Therapy in Reducing Child Pain During Local Anesthesia Injection

Sponsor
Aliaa Hamouda (Other)
Overall Status
Recruiting
CT.gov ID
NCT05861154
Collaborator
(none)
64
1
2
7
9.2

Study Details

Study Description

Brief Summary

This study aimed to evaluate the impact of laser photobiomodulation therapy used as pre-anesthetic technique to reduce child pain during local anesthesia administration

Condition or Disease Intervention/Treatment Phase
  • Device: Photobiomodulation
  • Drug: Benzocaine Gel
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
64 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Effectiveness of Laser Photobiomodulation Therapy in Reducing Child Pain During Local Anesthesia Injection (a Randomized Controlled Clinical Trial)
Actual Study Start Date :
Dec 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Jul 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Photobiomodulation

Device: Photobiomodulation
A diode laser (Sirolaser blue laser system, Sirona Dental Systems GmbH, Fabrikstraße 31, 64625 Bensheim, Germany) of Wavelength 660 nm will be used and the laser parameters will be set as follows: Power 0.1 W, energy 6 J, Continuous wave, Irradiation time 60 Seconds; energy Tip area 0.5 cm2, fluence 12 J/cm2 will be applied at the site of needle penetration. It should be noted that before each application, the output of the laser device will be checked using the aiming beam on flat surface; both the patient and the operator will wear safety goggles during the irradiation.

Active Comparator: Topical anesthesia

Drug: Benzocaine Gel
a 20% Benzocaine topical anaesthetic gel will be applied. To increase the absorption of the topical anaesthetic gel, soft tissues will be dried with (2 x 2 cm) gauze. Topical anaesthetic gel will be applied at the site of needle penetration and left in contact with the soft tissues for one minute in order to to maximize its effect.

Outcome Measures

Primary Outcome Measures

  1. Heart Rate [during local anesthesia administration]

    A brief demonstration of the pulse oximeter will be performed, and the patient will be instructed to remain still and avoid hand movement in order to obtain accurate readings. The pulse oximeter will be placed on the patient's index finger to measure the baseline heart rate (prior to administering the LA), and another measurement will be taken during the LA administration. Heart rate will be recorded at 2-minute intervals and the mean heart rate measurement will be calculated.

  2. Pain Reaction [during local anesthesia administration]

    The Sound, Eye, Motor (SEM) Scale will be used to assess pain. It encompasses the following parameters: (1) Sound, (2) Eye and (3) Motor. The sounds, eye symptoms and body movements of each child will be independently evaluated by a blind impartial observer using the recorded video tapes. The slightest manifestation of the patient's sound, eyes, or motion is graded in four levels: comfort, mild, moderate, and severe discomfort, and subsequently given grades 1, 2, 3, 4, respectively. The SEM score will be calculated by adding the three parameter grades.

  3. Perceived Pain [immediately after local anesthesia administration]

    To subjectively record pain during LA injection, a modified face scale will be used. It comprises three schematic faces with different facial expressions for happy and sad faces representing: (A) satisfaction; (B) indifference; and (C) dissatisfaction, respectively. Each child will be taught before injection how to use the scale by modelling and then asking each participant to recall the last time she or he felt something painful and select the facial expression that best represented his or her experience of discomfort.

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 7 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Completion of the written informed consent form by parents/guardian.

  • Children with dental behavior score of 3 or 4 according to the Frankel behavior rating scale.

  • Patients whom their maxillary primary molars are indicated for pulpotomy and SSC restoration.

  • Lack of history of allergy to the materials used for anesthesia and sulfite

  • Children free of any systemic disease or special health care needs (ASA 1)

Exclusion Criteria:
  • Children who receive any analgesic drugs at least 24 hours before treatment.

  • Any inflammation or lesion in the injection site

  • Patients who have previous bad experience of dentistry were excluded to eliminate the possible impact of the child's previous painful or stressful experiences

  • Child coming for emergency treatment of pain

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Dentistry, Alexandria University Alexandria Egypt 21527

Sponsors and Collaborators

  • Aliaa Hamouda

Investigators

  • Principal Investigator: Aliaa Hamouda, MSc, Alexandria University
  • Study Chair: Amani Khalil, PhD, Alexandria University
  • Study Director: Laila El-Habashy, PhD, Alexandria University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aliaa Hamouda, Assistant Lecturer of Pediatric Dentistry, Alexandria University
ClinicalTrials.gov Identifier:
NCT05861154
Other Study ID Numbers:
  • #11
First Posted:
May 16, 2023
Last Update Posted:
May 16, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 16, 2023